With 30+ years as a Mental Health Trauma Therapist, Patricia realized that there was insufficient capacity in that role to give people what they needed to be fully in charge of their total health. She embarked on a 10-year journey of studying valid Functional research to increase her ability to empower people with the proper knowledge, tools, and resources to allow them to be more in charge of their whole health.
John E. Lewis, Ph.D. is the founder and chief science officer of Nurish.Me Inc. He is also a past full-time associate professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine and now remains as a voluntary associate professor. He is a diplomate, faculty member, and advisor of the Medical Wellness Association. Dr. Lewis has been the principal investigator of multiple nutrition, dietary supplement, exercise training, and medical device clinical trials and studies in the last 2 decades. Much of his research has included investigating the effects of interventions on a wide variety of outcomes, including immune and cognitive functioning, inflammation, physical fitness, nutrient status, quality of life, and mental health, in healthy adults and in those with Alzheimer’s, HIV, MS, non-alcoholic fatty liver disease, diabetes, chronic pain, and GI disorders, among others. He has co-authored more than 170 peer-reviewed scientific articles, has mentored many undergraduate, graduate, and medical students in exercise, nutrition, and health promotion, and has been an invited speaker at multiple international and national conferences, including a seminal talk on the results of his work in Alzheimer’s for TEDxMiami. In addition to his professional accomplishments, he is a former athlete and competitive body builder, who maintains a very rigorous exercise training regimen and has eaten a whole-food, plant-based diet for over 23 years.
Alka Patel is a GP, Health Coach and Lifestyle Medicine Physician in the UK. She is a Regional Director of the British Society of Lifestyle Medicine, a Member of the Royal College of GPs Wellbeing Committee and a GP for the Practitioner Health Service providing a confidential service to doctors and dentist suffering with significant mental health issues and addictions.
Abouchacra is a consultant nephrologist with Canadian & American Board certification in Internal Medicine & Nephrology. She has Masters in Science from Toronto Institute of Medical Sciences. She served as chairperson for Academic Affairs & Nephrology departments at Tawam Hospital and Medical Director of Urology Kidney Disease Service Line Council for Emirate of Abu Dhabi. She has held Director of Outpatient Services post at Tawam and Al Ain Hospitals. She actively participates in teaching and research including International Dialysis Outcomes &Practice Patterns Study. She is an active member in medical societies & fellow of American Society of Nephrology.
Obesity has become a global epidemic, which is rapidly spreading at phenomenal rates. The gravity of this “Globesity” epidemic goes beyond sheer numbers, as it is directly linked to many diseases that pose serious health risks and are responsible for escalating health care expenditures. Notably, obesity is the single most important contributor to the development of type 2 diabetes along with other metabolic disorders; comprising the constellation of cardiovascular risks. In this presentation, the magnitude of this crisis and its hidden consequences will be delineated setting the stage for the necessary actionable steps. Though the solution seems straightforward with weight reduction being the cardinal intervention, however, achieving and maintaining weight loss is extremely challenging. Diets have disappointingly had limited short term benefits with lack of sustainability and even rebound weight gain. In addition to their restrictive nature, there are even more complex personal behaviour and social factors affecting food ingestion that current day “diets” do not address. These shortcomings will be explored in the context of dietary behaviour patterns promoting weight gain that may be critical in sabotaging weight loss efforts. Our research group has undertaken study initiatives including a multicentre survey aimed at understanding eating habits in overweight and obese individuals in our region. The published data will be shared for interactive discussion and a recently published novel eating behaviour modification concept will be introduced. This lecture aims to provide an evidence- based presentation intended specifically for the target audience with compelling take-home messages.
Azemsi Gul Yilmaz has completed her Bachelor’s degree from Gazi University’s Department of Nutrition and Dietetics in Ankara after graduating from primary school and high school in Konya. She completed her Master's degree in Department of Nutrition and Dietetics at Ankara University in 2015. Also, she is a Research Assistant at the same university. She is interested in obesity, nutrigenetics, nutrigenomics and genotoxicity.
Many foods and drinks contain caffeine (1, 2, 7 trimethylxanthine) as purine alkaloids. On beside of coffee, caffeine can also be taken from drinks such as tea, cola, cocoa and energy drinks. Furthermore caffeine is part of frequently used drugs such as flu medicines, painkillers, slimming pills and stimulating drugs. Caffeine has effects on the body such as staying awake, reducing physical fatigue, increasing performance, increasing attention due to its stimulating properties. Recent studies on caffeine have found that this substance has many effects on the heart and circulatory system, respiratory system and endocrine system as well as the central nervous system. The stimulating effect of caffeine on the specific nervous system makes individuals more vigilant and alerted to the effects on the cardiovascular system as well as accelerating heart rate and vasodilatation by expanding blood vessels. It is a very important stimulating particle as it is found that it results in many complications, such as; insomnia, headache, impaired concentration, rise in heart rate and blood pressure, stomach problems, spontaneous abortions in pregnant women, babies with low birth weight and the diuretic effect. Depending on high dose caffeine consumption (400 mg/kg/day) it also adversely affects bone health and increases the risk of post-menopausal osteoporosis. On the other hand, it is shown that caffeine consumed in appropriate levels positively effects human health. Caffeine alleviates the physical and mental fatigue and thus increases work capacity. It increases alertness and mindfulness and in some cases, it eases headache and migraine pains. Therefore, caffeine is one of the most researched and discussed molecules of recent times.
Nooshin Yoshany is PhD candidate in health education & promotion at Shahid Sadoughi University of medical sciences. She is the executive manager in Social Behavior Research & Health journal. She also works in Social Determinants of Health Research Center since 2013.
Francois Andre Allaert is a Medical Doctor specialized in Public Health, completed his PhD in Biostatistics and Pharm D. He is strongly involved in the field of Medical Evaluation and especially in the evaluation of health claim. He is managing a human clinical center specifically approved by French health authorities for food supplement and enriched food evaluation. He is also managing the Chair for Health Claim Medical Evaluation at the Burgundy University of Dijon. He authored more than 1500 scientific oral communications and publications among which 210 are PubMed referred.
In the European Regulation 1924/2006 and especially its first recital; the evaluation of health claims (HC) by European Food Safety Agency (EFSA) was introduced so as “to ensure a high level of consumer protection, [and] give the consumer the necessary information to make choices in full knowledge of the facts…” Now, with 10 years of hindsight since the Regulation was adopted, it can be asked whether EFSA HC process of evaluation that led to a marginal number of accepted claims is consistent with this objective, not just for protecting consumers but for allowing them to decide freely and make informed choices. The aim of this paper is to demonstrate that the inclusion of a ranking of the weight of evidence in the assessment of EFSA’s scientific substantiation of HC would allow consumers to benefit from the very high standard of scientific evaluation performed by EFSA. The definition of standards of proof is a generalized practice and rests on the principle that evaluations of health practices should be understood in terms of descriptions ranging from formal proof from high-power double-blind placebo-controlled studies to rankings based on the consensus views of experts or even agreement among professionals. Grading of weight of evidence – not of scientific expertise – is pervasive in all the recommendations or consensus meetings of health authorities or learned societies. This approach would stimulate research and product innovation as industrials would see a positive return on investment. The transition from an all-or-nothing system of health claims to a system graded by weight of evidence would be an alternative to the current system. This approach would be more consistent with the rationale of European Regulation which aims both to provide consumers with the best possible information by giving them the opportunity to exercise their free will in full knowledge of the facts and to promote research that meets sound scientific and medical grounds providing a basis for such information.